Nines wins FDA clearance for AI lung nodule measurement

By staff writers

March 30, 2021 -- Teleradiology services provider Nines has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for NinesMeasure, a semiautomatic artificial intelligence (AI)-based application for measuring lung nodules on chest CT exams.

Radiologists can utilize NinesMeasure to measure the long and short axes of selected nodules, according to the company. It can also help to address interstudy consistency over the course of a patient's treatment program, Nines said.

The FDA clearance is the second for Nines. The firm received FDA clearance in April 2020 for NinesAI, a computer-assisted triage application for automated review of head CT studies for intracranial hemorrhage and mass effect.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking